Childhood Obesity Risk Assessment Longitudinal Study

Childhood obesity is a major public health problem worldwide. Europe has a high prevalence of obesity, which is accentuated in Mediterranean countries. Spain has a high prevalence of both overweight (percentage: 21.5 in boys and 22.2 in girls) and obesity (percentage: 10.6 in boys and 11.8 in girls) in children aged 6-9 years. From childhood, obesity is associated with an increased risk of diseases such as insulin resistance, type 2 diabetes, hypertension, metabolic syndrome, musculoskeletal problems, sleep disorders and mental health problems. Obesity is a complex, multi-causal problem involving individual risk factors such as behavior and genetics. Behavioral factors include diet, physical activity, sedentary lifestyle, sleep, and others. It is therefore important to study each of the individual risk factors for obesity. There are few large sample studies in European/Spanish children and no longitudinal studies estimating the incidence of obesity in preschool children based on exposure to different risk factors, considering not only the effect of food consumption but also dietary habits and patterns. The aim of the present study is to identify risk factors for childhood obesity through long-term longitudinal follow-up.

NCT Number	NCT06317883
Lead Sponsor	Consorcio Centro de Investigación Biomédica en Red (CIBER) Collaborators: Instituto de Salud Carlos III, Maimónides Biomedical Research Institute of Córdoba, Universidad de Córdoba, Institut Investigacio Sanitaria Pere Virgili, University Rovira i Virgili, Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición, Universidad de Zaragoza, University of Valencia, University of Navarra, Hospital Clinico Universitario de Santiago, University of Santiago de Compostela, Health Research Institute of Santiago, Hospital del Mar Research Institute (IMIM), Hospital Universitario Reina Sofia de Cordoba, Universidad de Granada, Biosanitary Research Institute of Granada
Conditions	Child Obesity
Enrollment	1,508 participants
Start Date	2019-05-27
Primary Completion	2032-07-14 (estimated)
Study Completion	2032-07-14 (estimated)
Updated on ClinicalTrials.gov	2024-05-30